Brief: Rosetta Genomics prices public offering of 1.95 mln units at $1.40/unit
04/08/2017 13:15
Aug 4 (Reuters) - Rosetta Genomics Ltd ROSG.O
* Rosetta genomics says priced public offering of 1.95
million units at effective purchase price of $1.40 per unit
Source text for Eikon: (http://bit.ly/2v54Dy2)
Further company coverage: ROSG.O
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Rosetta Genomics
See all newsBrief: Interpace Diagnostics Acquires Select Assets Of Rosetta Genomics Out Of Bankruptcy
Brief: Stockholders Approve Genoptix Acquisition Of Rosetta Genomics
Brief: Rosetta Genomics Announces Shareholder Approval Of Merger With Genoptix
Brief: Sabby Management Buys 105,361 ADR Shares Of Rosetta Genomics
Brief: Genoptix Announces Termination Of Merger Agreement With Rosetta Genomics